Comparative efficacy and safety of targeted therapies for BRAF-mutant unresectable or metastatic melanoma: Results from a systematic literature review and a network meta-analysis (vol 110, 102463, 2022)

被引：0
|
作者：
Corrie, Pippa [1 ]
Meyer, Nicolas [2 ,3 ,4 ]
Berardi, Rossana [5 ,6 ]
Guidoboni, Massimo [7 ]
Schlueter, Maximilian [8 ]
Kolovos, Spyros [9 ]
Macabeo, Berengere [10 ,11 ]
Trouiller, Jean-Baptiste [10 ,11 ]
Laramee, Philippe [10 ,11 ]
机构：
[1] Cambridge Univ Hosp NHS Fdn Trust, Dept Oncol, Cambridge CB2 0QQ, England
[2] Inst Univ Canc, Toulouse, France
[3] CHU Toulouse, Toulouse, France
[4] CRCT, Inserm UMR 1037, Toulouse, France
[5] AOU Osped Riuniti, Clin Oncol, Ancona, Italy
[6] Univ Politecn Marche, Ancona, Italy
[7] IRCCS IRST Dino Amadori, Expt & Clin Oncol Immunotherapy & Rare Tumors, Meldola, Italy
[8] IQVIA, London, England
[9] IQVIA, Athens, Greece
[10] Aix Marseille Univ, Marseille, France
[11] Pierre Fabre Labs, Paris, France
来源：
CANCER TREATMENT REVIEWS | 2023年 / 112卷
关键词：
D O I：
10.1016/j.ctrv.2022.102495
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Comparative efficacy and safety of targeted therapies for BRAF-mutant unresectable or metastatic melanoma: Results from a systematic literature review and a network meta-analysis
    Pippa, Corrie
    Nicolas, Meyer
    Rossana, Berardi
    Massimo, Guidoboni
    Maximilian, Schlueter
    Spyros, Kolovos
    Berengere, Macabeo
    Jean-Baptiste, Trouiller
    Philippe, Laramee
    CANCER TREATMENT REVIEWS, 2022, 110
  • [2] Considerations regarding a network meta-analysis of targeted therapies for BRAF-mutant unresectable or metastatic melanoma
    Rizzo, Alessandro
    CANCER TREATMENT REVIEWS, 2022, 111
  • [3] Response to 'considerations regarding a network meta-analysis of targeted therapies for BRAF mutant unresectable or metastatic melanoma'
    Corrie, Pippa
    Meyer, Nicolas
    Berardi, Rossana
    Guidoboni, Massimo
    Schlueter, Max
    Kolovos, Spyros
    Macabeo, Berengere
    Trouiller, Jean-Baptiste
    Laramee, Philippe
    CANCER TREATMENT REVIEWS, 2022, 111
  • [4] Acceptability of Drugs in the Treatment of Unresectable/Metastatic BRAF V600-Mutant Melanoma: A Systematic Review and Network Meta-Analysis
    Hong, Ling
    Huang, Ping
    Zheng, Xiaochun
    Ye, Xiaolan
    Zhao, Hongying
    Wang, Jianwei
    Shao, Yanfei
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [5] Comparative efficacy and safety of immune checkpoint inhibitors for unresectable advanced melanoma: A systematic review and network meta-analysis
    Li, Yan
    Liang, Xueyan
    Li, Huijuan
    Chen, Xiaoyu
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 115
  • [6] Efficacy and safety of immune checkpoint inhibitors and targeted therapies in resected melanoma: a systematic review and network meta-analysis
    Sheng, Feng
    Yan, Yulan
    Zeng, Baoqi
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [7] Comparative Efficacy and Safety of Targeted Therapies for Chronic Thromboembolic Pulmonary Hypertension: A Systematic Review and Network Meta-Analysis
    Chen, Yusi
    Li, Fang
    Luo, Jun
    Chen, Jingyuan
    Luo, Peng
    Li, Jiang
    CANADIAN RESPIRATORY JOURNAL, 2021, 2021
  • [8] Efficacy and safety of dabrafenib-trametinib in the treatment of unresectable advanced/metastatic melanoma with BRAF-V600 mutation: A systematic review and network meta-analysis
    Garzon-Orjuela, Nathaly
    Prieto-Pinto, Laura
    Lasalvia, Pieralessandro
    Herrera, Daniel
    Castrillon, Johanna
    Gonzalez-Bravo, Diana
    Castaneda-Cardona, Camilo
    Rosselli, Diego
    DERMATOLOGIC THERAPY, 2020, 33 (02)
  • [9] Comparative efficacy and safety of current therapies for early rheumatoid arthritis: a systematic literature review and network meta-analysis
    Paul, D.
    Fazeli, M. S.
    Mintzer, L.
    Duarte, L.
    Gupta, K.
    Ferri, L.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2020, 38 (05) : 1008 - 1015
  • [10] SYSTEMATIC LITERATURE REVIEW AND NETWORK META-ANALYSIS OF IMMUNOTHERAPY, TARGETED AGENTS, OR COMBINATION REGIMENS IN TREATMENT-NAIVE UNRESECTABLE OR METASTATIC MELANOMA
    Lee, J.
    Kuzmicheva, V
    Lopatina, K.
    Barnieh, L.
    Janeiro, M. J.
    Sharma, R.
    Paranthaman, N.
    VALUE IN HEALTH, 2022, 25 (01) : S34 - S34
12345